Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow A
Agilent Technologies, Inc. (A) Shares outstanding
Agilent Technologies, Inc.'s shares outstanding at the end of fiscal 2025 was $285.0M, unchanged from fiscal 2024. At the end of the quarter to 31 July 2026 it was $283.0M. Over the past ten years it has ranged from $285.0M (fiscal 2025) to $335.0M (fiscal 2015) — the current reading is the lowest in ten years. Agilent Technologies, Inc. ranks 6th of 52 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $285.0M | (2.06%) |
| FY2024 | $291.0M | (1.69%) |
| FY2023 | $296.0M | (1.33%) |
| FY2022 | $300.0M | (2.28%) |
| FY2021 | $307.0M | (1.60%) |
| FY2020 | $312.0M | (1.89%) |
| FY2019 | $318.0M | (2.15%) |
| FY2018 | $325.0M | (0.31%) |
| FY2017 | $326.0M | (0.91%) |
| FY2016 | $329.0M | (1.79%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jul 2026 | $283.0M | 0.00% |
| Apr 2026 | $283.0M | (0.35%) |
| Jan 2026 | $284.0M | (0.35%) |
| Oct 2025 | $285.0M | 0.00% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| A Agilent Technologies, Inc. | $283.0M |
| IQV IQVIA Holdings Inc. compare | $167.3M |
| ILMN Illumina, Inc. compare | $153.0M |
| NTRA Natera, Inc. compare | $143.3M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| WAT Waters Corporation compare | $98.2M |
| LH Labcorp Holdings Inc. compare | $82.0M |
| IDXX IDEXX Laboratories, Inc. compare | $79.3M |
| MTD Mettler-Toledo International, Inc. compare | $20.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement